CAD - Coronary Artery Disease
11
5
5
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (11)
Low-dose Colchicine for CABG Graft Failure Prevention
Risk Stratification of MACE in Heart Failure Patients Who Undergoing CABG
Chronic Total Occlusion and Triglyceride-Glucose Index
Comparative Analysis of Analgesic Approaches in the Early Period After CABG
Advanced NanoTherapies Dual-API DCB to Treat De-Novo and ISR Lesions in Patients With Symptomatic Coronary Artery Disease
Effect of Empagliflozin on Inflammation
Registry of Coronary Disease Outcomes Revascularizing With Drug-Coated Balloons
REgistry of Paclitaxel Coated Drug Eluting Balloon in All Comers PaTients
Establishment of a Cohort for Continuous Coronary Artery CTA Scanning and Predictive Analysis of Plaque Progression
Extensively Diseased Left Anterior Descending Coronary Artery: On Pump vs Off Pump CABG?
Angiogram Based Fractional Flow Reserve FFRangio - A Validation Study